Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2015-06-05, 15:15:11 | version 1.38.0
implants2_2015 48 I NEWS SEM examined and qualitatively/quantitatively analysed65implantsystemsinanewintermediatere- port titled “Surface analysis of sterile-packaged im- plants”by Dr Dirk Duddeck and Dr Jorg Neugebauer, PhD, in cooperation with the European Association of Dental implantologists BDIZ-EDI. The report, which was conducted at the University of Cologne in Ger- many,rankedMISasoneofthetopcompetitorsinalist of implant providers. As a continuance to previous works,theaimofthestudywastoverifyimprovements of manufacturing and quality management as well as to demonstrate the high quality level of the participat- ingmanufacturersandimplantcompanies. “MISgoestogreatlengthstoensurethesurfacepurity ofourimplants”,saysDrTalReinerPhD,MISMaterials DisciplineManager,“andthisisthesecondsuchinde- pendent study published within the past 12 months thatverifiesourclaims.” “I’m very pleased with the results of this study; how- everitdoesn’treallysurpriseus,”sheconfides.“Main- taining the highest standards in both implant surface topography and chemical composition are of vital im- portanceatMIS.Ouraimistoconsistentlyproduceim- plantswithanidealsurfaceroughness;microandnano porosity,usingadvancedsand-blastingandacid-etch- ing techniques, and to attain a near flawless surface purity.” Putting things into perspective, Dr Reiner concludes, “The reason for investing all this time and effort isn’t just to look good in research studies.It’s to supply our customers, implantology professionals around the world,with the highest quality implants in the market ─ implants that are exceptionally biocompatible and encourage quick reliable integration into bone, for long-termpredictableresults.” MIS outclasses competitors in New implant surface quality study Straumann has signed an agreement to increase its ownership of Neodent, Latin America’s leading dental implant company, from 49% to 100% in 2015, three years earlier than foreseen in a previ- ous option agreement.The purchase price for the outstanding 51% is BRL 680 million (approxi- mately CHF 210 million) paid in cash to the com- pany’s founding shareholders, Drs Clemilda de PaulaThomé and GeninhoThomé.The acquisition extends Straumann’s overall leadership in implant dentistry and makes the Group a substantial con- tender in the global value segment. Neodentspecialisesprimarilyinthedesign,devel- opment, and manufacture of dental implants and related prosthetic components. Under the entre- preneurial leadership of its founders,the company has expanded rapidly over the past 22 years and has a leading share of the world’s second largest market for implant dentistry, Brazil. This success hasbeenachievedthroughaphilosophyofmaking tested implant solutions more affordable to a broader population. In2014,thecompanyachievedrevenuesofBRL258 million, generated predominantly in its domestic market,whererevenuegrew8%.Neodentishighly profitable and the acquisition will be accretive to Straumann’sreportedEBITmarginfrom2016. Straumann acquired 49% of Neodent in 2012 for BRL549million(CHF260million),withanoptionto increaseto75%in2015andupto100%by2018. This option has been renegotiated to enable a full acquisition in 2015. Straumann increases Ownership of Neodent to 100 per cent The various countries in theAsia Pacific region are allexpectedtodemonstrateanincreasingdemand for dental implant treatments as a result of grow- ing consumer awareness, the ageing population, growingaccessibility(suchasthroughtheNational Health Insurance Service coverage in South Ko- rea), as well as greater product availability and other influencing factors. Traditionally, premium implantcompanieshavedominatedthedentalim- plant market globally. However, in recent years, discounted implants have become increasingly popular,especially in theAsia Pacific region. The growing acceptance of discount implants has been driven by Korean companies. The regional market leader, OSSTEM IMPLANT, held a 21.9% share of the total dental implant market for the Asia Pacific region in 2014.The company has invested sig- nificantly in marketing efforts, which has led to the growing popularity of its products. Throughout the forecast pe- riod,OSSTEMIMPLANTandotherdiscountimplant companies, such as MegaGen, Dentium and Neo- biotech, are expected to capitalise on the growing popularity of discount implants. In contrast, pre- mium implant companies,such as Straumann and Nobel Biocare, are expected to face increasing competitive pressures, especially in China and Australia. Opposing pricing trends to influence Asia Pacific dental implant market [PICTURE: ©KRITCHANUT] [PICTURE: ©MMAXER] [PICTURE: ©MIS]